Ecofriendly synthesis characterization and biological activities of Eruca sativa mediated silver oxide nanoparticles
One of the popular subjects of millennia is the synthesis of nanostructures, their applications in numerous fields, and their interaction with various biological systems, making them appealing for drug delivery systems, and diagnostic and therapeutic agents. In this study, silver oxide nanoparticles...
Saved in:
| Published in | Scientific reports Vol. 15; no. 1; pp. 13466 - 18 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
18.04.2025
Nature Publishing Group Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | One of the popular subjects of millennia is the synthesis of nanostructures, their applications in numerous fields, and their interaction with various biological systems, making them appealing for drug delivery systems, and diagnostic and therapeutic agents. In this study, silver oxide nanoparticles were synthesized using
E. sativa
(ES) aqueous extract. The biosynthesis was followed via UV-vis spectroscopy by analysis, FTIR, XRD, TEM, and Zeta potential to further analyze the synthesized nanoparticles. Furthermore, the biosynthesized silver oxide nanoparticles (Ag
2
ONPs) were checked through various biological activities. The antioxidative potential was assessed by performing a DPPH radical scavenging assay, total reducing power assay, and total antioxidant capacity assay. Antimicrobial potential was observed against various bacterial and fungal strains. Likewise,
Artemia salina
(brine shrimps) was used to study cytotoxicity, while VERO and HEK-293 cell lines were applied to check the biocompatibility of synthesized NPs. Anticancer potential was evaluated against the Hep-2 cells by utilizing an MTT assay. A mean crystallite ~ 50 nm size is evidenced by TEM analysis. Notable antimicrobial activity was detected with various bacterial and fungal strains with maximum ZOI by
B
.
subtilis
was 18.5 ± 2.36 mm at 1000 µg/mL and
A
.
niger
reveals a minimum ZOP of 16 ± 1.7 mm at 1000 µg/mL respectively. A dose-dependent response was observed in biological evaluation against
A
.
salina
(LC
50
: 12.21 µg/mL), DPPH (IC
50
: 62.36 µg/mL), VERO cell line (IC
50
: 43.11 µg/mL), HEK-293 cell line (IC
50
: 26.56 µg/mL), and Hep-2 cell line (IC
50
: 9.97 µg/mL). The multifaceted attributes of ES-Ag
2
ONPs encompassing antimicrobial, antioxidant, cytotoxic, and anticancer properties render them a versatile platform in drug delivery and biomedical horizons. However, detailed investigation and clinical trials will undoubtedly provide translational applications in diverse fields. |
|---|---|
| AbstractList | Abstract One of the popular subjects of millennia is the synthesis of nanostructures, their applications in numerous fields, and their interaction with various biological systems, making them appealing for drug delivery systems, and diagnostic and therapeutic agents. In this study, silver oxide nanoparticles were synthesized using E. sativa (ES) aqueous extract. The biosynthesis was followed via UV-vis spectroscopy by analysis, FTIR, XRD, TEM, and Zeta potential to further analyze the synthesized nanoparticles. Furthermore, the biosynthesized silver oxide nanoparticles (Ag2ONPs) were checked through various biological activities. The antioxidative potential was assessed by performing a DPPH radical scavenging assay, total reducing power assay, and total antioxidant capacity assay. Antimicrobial potential was observed against various bacterial and fungal strains. Likewise, Artemia salina (brine shrimps) was used to study cytotoxicity, while VERO and HEK-293 cell lines were applied to check the biocompatibility of synthesized NPs. Anticancer potential was evaluated against the Hep-2 cells by utilizing an MTT assay. A mean crystallite ~ 50 nm size is evidenced by TEM analysis. Notable antimicrobial activity was detected with various bacterial and fungal strains with maximum ZOI by B. subtilis was 18.5 ± 2.36 mm at 1000 µg/mL and A. niger reveals a minimum ZOP of 16 ± 1.7 mm at 1000 µg/mL respectively. A dose-dependent response was observed in biological evaluation against A. salina (LC50: 12.21 µg/mL), DPPH (IC50: 62.36 µg/mL), VERO cell line (IC50: 43.11 µg/mL), HEK-293 cell line (IC50: 26.56 µg/mL), and Hep-2 cell line (IC50: 9.97 µg/mL). The multifaceted attributes of ES-Ag2ONPs encompassing antimicrobial, antioxidant, cytotoxic, and anticancer properties render them a versatile platform in drug delivery and biomedical horizons. However, detailed investigation and clinical trials will undoubtedly provide translational applications in diverse fields. One of the popular subjects of millennia is the synthesis of nanostructures, their applications in numerous fields, and their interaction with various biological systems, making them appealing for drug delivery systems, and diagnostic and therapeutic agents. In this study, silver oxide nanoparticles were synthesized using E. sativa (ES) aqueous extract. The biosynthesis was followed via UV-vis spectroscopy by analysis, FTIR, XRD, TEM, and Zeta potential to further analyze the synthesized nanoparticles. Furthermore, the biosynthesized silver oxide nanoparticles (Ag ONPs) were checked through various biological activities. The antioxidative potential was assessed by performing a DPPH radical scavenging assay, total reducing power assay, and total antioxidant capacity assay. Antimicrobial potential was observed against various bacterial and fungal strains. Likewise, Artemia salina (brine shrimps) was used to study cytotoxicity, while VERO and HEK-293 cell lines were applied to check the biocompatibility of synthesized NPs. Anticancer potential was evaluated against the Hep-2 cells by utilizing an MTT assay. A mean crystallite ~ 50 nm size is evidenced by TEM analysis. Notable antimicrobial activity was detected with various bacterial and fungal strains with maximum ZOI by B. subtilis was 18.5 ± 2.36 mm at 1000 µg/mL and A. niger reveals a minimum ZOP of 16 ± 1.7 mm at 1000 µg/mL respectively. A dose-dependent response was observed in biological evaluation against A. salina (LC : 12.21 µg/mL), DPPH (IC : 62.36 µg/mL), VERO cell line (IC : 43.11 µg/mL), HEK-293 cell line (IC : 26.56 µg/mL), and Hep-2 cell line (IC : 9.97 µg/mL). The multifaceted attributes of ES-Ag ONPs encompassing antimicrobial, antioxidant, cytotoxic, and anticancer properties render them a versatile platform in drug delivery and biomedical horizons. However, detailed investigation and clinical trials will undoubtedly provide translational applications in diverse fields. One of the popular subjects of millennia is the synthesis of nanostructures, their applications in numerous fields, and their interaction with various biological systems, making them appealing for drug delivery systems, and diagnostic and therapeutic agents. In this study, silver oxide nanoparticles were synthesized using E. sativa (ES) aqueous extract. The biosynthesis was followed via UV-vis spectroscopy by analysis, FTIR, XRD, TEM, and Zeta potential to further analyze the synthesized nanoparticles. Furthermore, the biosynthesized silver oxide nanoparticles (Ag 2 ONPs) were checked through various biological activities. The antioxidative potential was assessed by performing a DPPH radical scavenging assay, total reducing power assay, and total antioxidant capacity assay. Antimicrobial potential was observed against various bacterial and fungal strains. Likewise, Artemia salina (brine shrimps) was used to study cytotoxicity, while VERO and HEK-293 cell lines were applied to check the biocompatibility of synthesized NPs. Anticancer potential was evaluated against the Hep-2 cells by utilizing an MTT assay. A mean crystallite ~ 50 nm size is evidenced by TEM analysis. Notable antimicrobial activity was detected with various bacterial and fungal strains with maximum ZOI by B . subtilis was 18.5 ± 2.36 mm at 1000 µg/mL and A . niger reveals a minimum ZOP of 16 ± 1.7 mm at 1000 µg/mL respectively. A dose-dependent response was observed in biological evaluation against A . salina (LC 50 : 12.21 µg/mL), DPPH (IC 50 : 62.36 µg/mL), VERO cell line (IC 50 : 43.11 µg/mL), HEK-293 cell line (IC 50 : 26.56 µg/mL), and Hep-2 cell line (IC 50 : 9.97 µg/mL). The multifaceted attributes of ES-Ag 2 ONPs encompassing antimicrobial, antioxidant, cytotoxic, and anticancer properties render them a versatile platform in drug delivery and biomedical horizons. However, detailed investigation and clinical trials will undoubtedly provide translational applications in diverse fields. One of the popular subjects of millennia is the synthesis of nanostructures, their applications in numerous fields, and their interaction with various biological systems, making them appealing for drug delivery systems, and diagnostic and therapeutic agents. In this study, silver oxide nanoparticles were synthesized using E. sativa (ES) aqueous extract. The biosynthesis was followed via UV-vis spectroscopy by analysis, FTIR, XRD, TEM, and Zeta potential to further analyze the synthesized nanoparticles. Furthermore, the biosynthesized silver oxide nanoparticles (Ag2ONPs) were checked through various biological activities. The antioxidative potential was assessed by performing a DPPH radical scavenging assay, total reducing power assay, and total antioxidant capacity assay. Antimicrobial potential was observed against various bacterial and fungal strains. Likewise, Artemia salina (brine shrimps) was used to study cytotoxicity, while VERO and HEK-293 cell lines were applied to check the biocompatibility of synthesized NPs. Anticancer potential was evaluated against the Hep-2 cells by utilizing an MTT assay. A mean crystallite ~ 50 nm size is evidenced by TEM analysis. Notable antimicrobial activity was detected with various bacterial and fungal strains with maximum ZOI by B. subtilis was 18.5 ± 2.36 mm at 1000 µg/mL and A. niger reveals a minimum ZOP of 16 ± 1.7 mm at 1000 µg/mL respectively. A dose-dependent response was observed in biological evaluation against A. salina (LC50: 12.21 µg/mL), DPPH (IC50: 62.36 µg/mL), VERO cell line (IC50: 43.11 µg/mL), HEK-293 cell line (IC50: 26.56 µg/mL), and Hep-2 cell line (IC50: 9.97 µg/mL). The multifaceted attributes of ES-Ag2ONPs encompassing antimicrobial, antioxidant, cytotoxic, and anticancer properties render them a versatile platform in drug delivery and biomedical horizons. However, detailed investigation and clinical trials will undoubtedly provide translational applications in diverse fields.One of the popular subjects of millennia is the synthesis of nanostructures, their applications in numerous fields, and their interaction with various biological systems, making them appealing for drug delivery systems, and diagnostic and therapeutic agents. In this study, silver oxide nanoparticles were synthesized using E. sativa (ES) aqueous extract. The biosynthesis was followed via UV-vis spectroscopy by analysis, FTIR, XRD, TEM, and Zeta potential to further analyze the synthesized nanoparticles. Furthermore, the biosynthesized silver oxide nanoparticles (Ag2ONPs) were checked through various biological activities. The antioxidative potential was assessed by performing a DPPH radical scavenging assay, total reducing power assay, and total antioxidant capacity assay. Antimicrobial potential was observed against various bacterial and fungal strains. Likewise, Artemia salina (brine shrimps) was used to study cytotoxicity, while VERO and HEK-293 cell lines were applied to check the biocompatibility of synthesized NPs. Anticancer potential was evaluated against the Hep-2 cells by utilizing an MTT assay. A mean crystallite ~ 50 nm size is evidenced by TEM analysis. Notable antimicrobial activity was detected with various bacterial and fungal strains with maximum ZOI by B. subtilis was 18.5 ± 2.36 mm at 1000 µg/mL and A. niger reveals a minimum ZOP of 16 ± 1.7 mm at 1000 µg/mL respectively. A dose-dependent response was observed in biological evaluation against A. salina (LC50: 12.21 µg/mL), DPPH (IC50: 62.36 µg/mL), VERO cell line (IC50: 43.11 µg/mL), HEK-293 cell line (IC50: 26.56 µg/mL), and Hep-2 cell line (IC50: 9.97 µg/mL). The multifaceted attributes of ES-Ag2ONPs encompassing antimicrobial, antioxidant, cytotoxic, and anticancer properties render them a versatile platform in drug delivery and biomedical horizons. However, detailed investigation and clinical trials will undoubtedly provide translational applications in diverse fields. One of the popular subjects of millennia is the synthesis of nanostructures, their applications in numerous fields, and their interaction with various biological systems, making them appealing for drug delivery systems, and diagnostic and therapeutic agents. In this study, silver oxide nanoparticles were synthesized using E. sativa (ES) aqueous extract. The biosynthesis was followed via UV-vis spectroscopy by analysis, FTIR, XRD, TEM, and Zeta potential to further analyze the synthesized nanoparticles. Furthermore, the biosynthesized silver oxide nanoparticles (Ag2ONPs) were checked through various biological activities. The antioxidative potential was assessed by performing a DPPH radical scavenging assay, total reducing power assay, and total antioxidant capacity assay. Antimicrobial potential was observed against various bacterial and fungal strains. Likewise, Artemia salina (brine shrimps) was used to study cytotoxicity, while VERO and HEK-293 cell lines were applied to check the biocompatibility of synthesized NPs. Anticancer potential was evaluated against the Hep-2 cells by utilizing an MTT assay. A mean crystallite ~ 50 nm size is evidenced by TEM analysis. Notable antimicrobial activity was detected with various bacterial and fungal strains with maximum ZOI by B. subtilis was 18.5 ± 2.36 mm at 1000 µg/mL and A. niger reveals a minimum ZOP of 16 ± 1.7 mm at 1000 µg/mL respectively. A dose-dependent response was observed in biological evaluation against A. salina (LC50: 12.21 µg/mL), DPPH (IC50: 62.36 µg/mL), VERO cell line (IC50: 43.11 µg/mL), HEK-293 cell line (IC50: 26.56 µg/mL), and Hep-2 cell line (IC50: 9.97 µg/mL). The multifaceted attributes of ES-Ag2ONPs encompassing antimicrobial, antioxidant, cytotoxic, and anticancer properties render them a versatile platform in drug delivery and biomedical horizons. However, detailed investigation and clinical trials will undoubtedly provide translational applications in diverse fields. |
| ArticleNumber | 13466 |
| Author | Gul, Farhat Uddin, Jamal Abbasi, Banzeer Ahsan Mahmood, Tariq Iqbal, Javed Ullah, Zakir Kazi, Mohsin Kanwal, Sobia Ali, Sarfaraz |
| Author_xml | – sequence: 1 givenname: Farhat surname: Gul fullname: Gul, Farhat organization: Department of Plant Sciences, Faculty of Biological Sciences, Quaid-i-Azam University – sequence: 2 givenname: Zakir surname: Ullah fullname: Ullah, Zakir email: zakirullah@bs.qau.edu.pk organization: Department of Plant Sciences, Faculty of Biological Sciences, Quaid-i-Azam University – sequence: 3 givenname: Javed surname: Iqbal fullname: Iqbal, Javed organization: Department of Botany, Bacha Khan University – sequence: 4 givenname: Banzeer Ahsan surname: Abbasi fullname: Abbasi, Banzeer Ahsan organization: Department of Botany, Rawalpindi Women University – sequence: 5 givenname: Sarfaraz surname: Ali fullname: Ali, Sarfaraz organization: Quality Control laboratory (Biological), National Institute of Health – sequence: 6 givenname: Sobia surname: Kanwal fullname: Kanwal, Sobia organization: Department of Biology and Environmental Sciences, Allama Iqbal Open University – sequence: 7 givenname: Jamal surname: Uddin fullname: Uddin, Jamal email: JUddin@coppin.edu organization: Center for Nanotechnology, Department of Natural Sciences, Coppin State University – sequence: 8 givenname: Mohsin surname: Kazi fullname: Kazi, Mohsin email: mkazi@ksu.edu.sa organization: Department of Pharmaceutics, College of Pharmacy, King Saud University – sequence: 9 givenname: Tariq surname: Mahmood fullname: Mahmood, Tariq email: tmahmood@qau.edu.pk organization: Department of Plant Sciences, Faculty of Biological Sciences, Quaid-i-Azam University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40251221$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1vEzEQhi1UREvpH-CALHHhsuCvtb0nhKoAlSpxgbM1sb2Jo40d7N2o4dfjZkNpOeCLrZnnfWdsz0t0FlP0CL2m5D0lXH8ogradbghrG62kIk33DF0wItqGccbOHp3P0VUpG1JXyzpBuxfoXFQZZYxeoHFhU5-Dj2444HKI49qXULBdQwY7-hx-wRhSxBAdXoY0pFWwMOCaC_swBl9w6vEiTxZwqeQe8Na7AKN3uIRh7zNOd8F5HCGmHeQx2MGXV-h5D0PxV6f9Ev34vPh-_bW5_fbl5vrTbWNFJ8amJ1YqrqwUbSuJ1EyRrvfOLhVznetBO2qVsFoJIWXLvQMtuOsY0dK2AJZfopvZ1yXYmF0OW8gHkyCYYyDllTm1ZKwjmlCiWiW40IyA9XzJnVOU9boGqtfH2Ws3LesVrY9jhuGJ6dNMDGuzSntDGSFaUFod3p0ccvo5-TKabSjWDwNEn6ZiOO2opJrotqJv_0E3acqxvtWREppKeW_45nFLD738-d0KsBmwOZWSff-AUGLup8jMU2SqwBynyHRVxGdRqXBc-fy39n9UvwGHn8sE |
| Cites_doi | 10.1016/j.jphotobiol.2017.03.023 10.1155/2014/256919 10.1021/acsomega.3c06233 10.1016/j.molstruc.2020.128490 10.1016/j.biopha.2016.09.016 10.1080/17460441.2022.2097659 10.1186/s12951-018-0408-4 10.1007/s11837-019-03784-2 10.3390/molecules21030365 10.1039/D0BM00029A 10.1038/s41598-024-60694-3 10.3390/biomedicines8050117 10.1016/j.msec.2015.08.022 10.3390/antibiotics11070853 10.1142/S0219581X21500605 10.1016/j.inoche.2021.109020 10.3390/ph15080968 10.1111/j.1365-2672.2012.05253.x 10.1016/j.biopha.2023.114687 10.1016/j.egypro.2017.03.035 10.22271/flora.2016.v4.i6c.03 10.1016/j.ultsonch.2017.11.001 10.1016/B978-0-323-95376-4.00012-5 10.1038/s41598-021-99839-z 10.1088/2053-1591/ab4f04 10.1002/aenm.202001119 10.1088/2053-1591/ab23e1 10.1016/j.apt.2022.103645 10.1002/jemt.23756 10.1016/j.jclepro.2019.05.157 10.2147/IJN.S122842 10.1093/mmy/myab028 10.1002/pi.5304 10.1021/acs.jafc.7b05830 10.2174/18756298MTA5jNzYp2 10.1016/j.colsurfa.2016.05.058 10.1093/cid/ciw691 10.3390/microorganisms11041069 10.1016/j.matchemphys.2019.121976 10.1021/acs.biomac.0c00726 10.1016/j.colsurfb.2020.111156 10.1155/2022/3863138 10.1016/j.molstruc.2023.136012 10.1016/j.ijid.2017.01.020 10.3390/su151612186 10.3390/molecules20058856 10.1039/C4AN00816B 10.3389/fmicb.2019.00008 10.1016/j.tiv.2011.01.004 10.1016/j.jphotobiol.2019.111650 10.1016/j.jphotobiol.2018.04.020 10.1016/j.talanta.2022.124026 10.3109/13880209.2014.986687 10.1016/j.jmii.2014.04.013 10.22159/ajpcr.2018.v11i1.21999 10.1002/jemt.23522 10.1007/s11356-023-25343-8 10.3389/fchem.2018.00360 10.1016/B978-0-443-15518-5.00024-0 10.1088/2043-6254/aaec0e 10.1002/jps.24001 10.1039/C4NR01405G 10.24966/NTMB-2044/100022 10.1007/s00775-019-01717-7 10.1021/acs.molpharmaceut.8b00640 10.1016/S1473-3099(16)00078-5 10.3389/fchem.2022.952006 10.1007/s11468-019-01101-w 10.3390/su151712783 10.22159/ajpcr.2018.v11i3.20858 10.1016/j.micres.2016.06.004 10.1016/j.apt.2018.03.025 10.4103/0250-474X.108420 10.3390/molecules28073240 10.1039/C7NJ02453C 10.1007/s13204-012-0125-5 10.1080/14787210.2019.1614914 10.1016/j.envpol.2019.113358 10.4172/0974-8369.1000363 10.1166/jnn.2017.12636 10.1016/j.heliyon.2021.e06923 10.1016/j.molstruc.2019.126979 10.22207/JPAM.14.3.48 10.1016/j.inoche.2020.108385 10.1016/B978-0-323-46139-9.00001-3 10.1016/j.bcab.2023.102870 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2025 2025. The Author(s). Copyright Nature Publishing Group 2025 The Author(s) 2025 2025 |
| Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: Copyright Nature Publishing Group 2025 – notice: The Author(s) 2025 2025 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.1038/s41598-025-87670-9 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 18 |
| ExternalDocumentID | oai_doaj_org_article_cd08010757434820ace3b3dd712f8482 PMC12008411 40251221 10_1038_s41598_025_87670_9 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Mohsin Kazi grantid: RSPD2024R994; RSPD2024R994; RSPD2024R994; RSPD2024R994; RSPD2024R994; RSPD2024R994; RSPD2024R994; RSPD2024R994 – fundername: Jamal Uddin grantid: RSPD2024R994; RSPD2024R994; RSPD2024R994; RSPD2024R994; RSPD2024R994; RSPD2024R994; RSPD2024R994; RSPD2024R994 – fundername: Mohsin Kazi grantid: RSPD2024R994 – fundername: Jamal Uddin grantid: RSPD2024R994 |
| GroupedDBID | 0R~ 4.4 53G 5VS 7X7 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD AASML ABDBF ABUWG ACGFS ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AFPKN ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M1P M2P M7P M~E NAO OK1 PHGZT PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AAYXX CITATION PHGZM CGR CUY CVF ECM EIF NPM 3V. 7XB 88A 8FK AARCD K9. M48 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c494t-f0c6737c645560682709fedcb72d9dfa8d1c74c87446653eda843d92086c5aac3 |
| IEDL.DBID | 7X7 |
| ISSN | 2045-2322 |
| IngestDate | Wed Aug 27 01:23:09 EDT 2025 Thu Aug 21 18:28:09 EDT 2025 Fri Jul 11 18:36:02 EDT 2025 Wed Aug 13 04:11:41 EDT 2025 Tue Apr 22 01:20:47 EDT 2025 Sun Jul 06 05:03:09 EDT 2025 Sat Apr 19 01:10:46 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Antimicrobial Silver oxide nanoparticles Cytotoxic Anticancer E. sativa |
| Language | English |
| License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c494t-f0c6737c645560682709fedcb72d9dfa8d1c74c87446653eda843d92086c5aac3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/3191481661?pq-origsite=%requestingapplication% |
| PMID | 40251221 |
| PQID | 3191481661 |
| PQPubID | 2041939 |
| PageCount | 18 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_cd08010757434820ace3b3dd712f8482 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12008411 proquest_miscellaneous_3191618085 proquest_journals_3191481661 pubmed_primary_40251221 crossref_primary_10_1038_s41598_025_87670_9 springer_journals_10_1038_s41598_025_87670_9 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-04-18 |
| PublicationDateYYYYMMDD | 2025-04-18 |
| PublicationDate_xml | – month: 04 year: 2025 text: 2025-04-18 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2025 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | N Liaqat (87670_CR49) 2022; 10 RRR Kannan (87670_CR42) 2013; 3 BA Abbasi (87670_CR48) 2020; 83 K Velsankar (87670_CR19) 2023; 53 J Iqbal (87670_CR38) 2021; 11 BA Abbasi (87670_CR30) 2019; 6 A Hussain (87670_CR89) 2019; 10 ER Swy (87670_CR2) 2014; 6 J Iqbal (87670_CR34) 2020; 1199 GA Rather (87670_CR25) 2021; 134 D Nayak (87670_CR85) 2016; 58 BR Sushobhan (87670_CR8) 2017; 109 H Houri (87670_CR56) 2017; 57 BA Abbasi (87670_CR35) 2020; 1218 P Balashanmugam (87670_CR78) 2016; 192 Z Ullah (87670_CR6) 2024; 14 A Benslama (87670_CR51) 2016; 4 AA El-Bassuony (87670_CR72) 2020; 72 J Singh (87670_CR40) 2018; 16 D Debnath (87670_CR92) 2017; 66 J Iqbal (87670_CR37) 2020; 8 T Khan (87670_CR61) 2020; 194 87670_CR44 R Ridolfo (87670_CR12) 2020; 22 I Hasan (87670_CR16) 2019; 230 H Vahidi (87670_CR28) 2020; 7 C Sharmila (87670_CR11) 2018; 11 87670_CR84 I Ullah (87670_CR93) 2020; 2020 K Velsankar (87670_CR41) 2023; 1291 D Zhang (87670_CR15) 2014; 139 87670_CR80 ZK Xia (87670_CR74) 2016; 49 JJ Artunduaga Bonilla (87670_CR76) 2021; 59 A Nasrollahi (87670_CR70) 2011; 5 AJ Adur (87670_CR64) 2018; 183 J Jampilek (87670_CR67) 2022; 17 JS Teodoro (87670_CR87) 2011; 25 NT Khan (87670_CR71) 2017; 9 RAD Lish (87670_CR81) 2019; 255 A Rónavári (87670_CR18) 2017; 12 S Majeed (87670_CR20) 2023; 253 S Francis (87670_CR23) 2017; 41 87670_CR32 V Castro-Aceituno (87670_CR90) 2016; 84 CA Dos Santos (87670_CR59) 2014; 103 A Behera (87670_CR91) 2021; 20 M Li (87670_CR14) 2020; 8 K Velsankar (87670_CR9) 2019; 200 S Bibi (87670_CR24) 2023; 8 HD Kabiru (87670_CR82) 2022; 8 A Zumla (87670_CR55) 2016; 16 A Zuhrotun (87670_CR46) 2023; 28 T Naseri (87670_CR7) 2020; 15 A Bouafia (87670_CR4) 2021; 18 S Ijaz (87670_CR86) 2023; 162 R Ullah (87670_CR31) 2023; 15 G Apsana (87670_CR10) 2018; 11 CS Yang (87670_CR47) 2018; 66 S Naraginti (87670_CR17) 2017; 170 ARG Ghomi (87670_CR26) 2019; 18 F Rodríguez-Félix (87670_CR65) 2021; 7 M Safarpoor (87670_CR73) 2018; 42 JS Eswari (87670_CR50) 2018; 9 S Shehensha (87670_CR79) 2020; 14 MK Rai (87670_CR60) 2012; 112 Z Ullah (87670_CR5) 2023; 15 P Dahiya (87670_CR53) 2012; 74 K Velsankar (87670_CR62) 2022; 33 87670_CR29 AM Awadelkareem (87670_CR88) 2022; 11 SV Gudkov (87670_CR39) 2022; 15 A Dziedzic (87670_CR83) 2016; 21 S Barua (87670_CR13) 2017; 17 87670_CR21 B Buszewski (87670_CR66) 2016; 506 Z Ullah (87670_CR43) 2023; 11 D Van Duin (87670_CR52) 2016; 30 K Velsankar (87670_CR45) 2020; 239 H Vahidi (87670_CR27) 2021; 124 D Dey (87670_CR54) 2015; 53 SR Lockhart (87670_CR69) 2017; 64 S Uddin (87670_CR33) 2021; 84 S Soares (87670_CR22) 2018; 6 M Wu (87670_CR3) 2020; 10 J Iqbal (87670_CR36) 2019; 6 B Ahmed (87670_CR68) 2018; 29 M Alavi (87670_CR57) 2019; 17 SA Akintelu (87670_CR63) 2019; 6 P Nisar (87670_CR75) 2019; 24 G Narasimha (87670_CR77) 2013; 7 G Franci (87670_CR58) 2015; 20 O Gotov (87670_CR1) 2018; 15 |
| References_xml | – volume: 170 start-page: 225 year: 2017 ident: 87670_CR17 publication-title: J. Photochem. Photobiol., B doi: 10.1016/j.jphotobiol.2017.03.023 – ident: 87670_CR80 doi: 10.1155/2014/256919 – volume: 8 start-page: 45750 issue: 48 year: 2023 ident: 87670_CR24 publication-title: ACS Omega doi: 10.1021/acsomega.3c06233 – volume: 1218 start-page: 128490 year: 2020 ident: 87670_CR35 publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2020.128490 – volume: 84 start-page: 158 year: 2016 ident: 87670_CR90 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2016.09.016 – volume: 17 start-page: 949 issue: 9 year: 2022 ident: 87670_CR67 publication-title: Expert Opin. Drug Discov. doi: 10.1080/17460441.2022.2097659 – volume: 16 start-page: 1 year: 2018 ident: 87670_CR40 publication-title: J. Nanobiotechnol. doi: 10.1186/s12951-018-0408-4 – volume: 72 start-page: 1154 issue: 3 year: 2020 ident: 87670_CR72 publication-title: JOM doi: 10.1007/s11837-019-03784-2 – volume: 21 start-page: 365 issue: 3 year: 2016 ident: 87670_CR83 publication-title: Molecules doi: 10.3390/molecules21030365 – volume: 8 start-page: 1802 issue: 7 year: 2020 ident: 87670_CR14 publication-title: Biomaterials Sci. doi: 10.1039/D0BM00029A – volume: 14 start-page: 10484 issue: 1 year: 2024 ident: 87670_CR6 publication-title: Sci. Rep. doi: 10.1038/s41598-024-60694-3 – volume: 8 start-page: 117 issue: 5 year: 2020 ident: 87670_CR37 publication-title: Biomedicines doi: 10.3390/biomedicines8050117 – volume: 58 start-page: 44 year: 2016 ident: 87670_CR85 publication-title: Mater. Sci. Engineering: C doi: 10.1016/j.msec.2015.08.022 – volume: 11 start-page: 853 issue: 7 year: 2022 ident: 87670_CR88 publication-title: Antibiotics doi: 10.3390/antibiotics11070853 – volume: 20 start-page: 2150060 issue: 06 year: 2021 ident: 87670_CR91 publication-title: Int. J. Nanosci. doi: 10.1142/S0219581X21500605 – volume: 134 start-page: 109020 year: 2021 ident: 87670_CR25 publication-title: Inorg. Chem. Commun. doi: 10.1016/j.inoche.2021.109020 – volume: 15 start-page: 968 issue: 8 year: 2022 ident: 87670_CR39 publication-title: Pharmaceuticals doi: 10.3390/ph15080968 – volume: 112 start-page: 841 issue: 5 year: 2012 ident: 87670_CR60 publication-title: J. Appl. Microbiol. doi: 10.1111/j.1365-2672.2012.05253.x – volume: 162 start-page: 114687 year: 2023 ident: 87670_CR86 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2023.114687 – volume: 109 start-page: 385 year: 2017 ident: 87670_CR8 publication-title: Energy Procedia doi: 10.1016/j.egypro.2017.03.035 – volume: 4 start-page: 158 issue: 6 year: 2016 ident: 87670_CR51 publication-title: Int. J. Herb. Med. doi: 10.22271/flora.2016.v4.i6c.03 – volume: 42 start-page: 76 year: 2018 ident: 87670_CR73 publication-title: Ultrason. Sonochem. doi: 10.1016/j.ultsonch.2017.11.001 – ident: 87670_CR29 doi: 10.1016/B978-0-323-95376-4.00012-5 – volume: 11 start-page: 20988 issue: 1 year: 2021 ident: 87670_CR38 publication-title: Sci. Rep. doi: 10.1038/s41598-021-99839-z – volume: 6 start-page: 115407 issue: 11 year: 2019 ident: 87670_CR36 publication-title: Mater. Res. Express doi: 10.1088/2053-1591/ab4f04 – volume: 5 start-page: 523 issue: 4 year: 2011 ident: 87670_CR70 publication-title: Int. J. Appl. Sci. Biotechnol. – volume: 10 start-page: 2001119 issue: 25 year: 2020 ident: 87670_CR3 publication-title: Adv. Energy Mater. doi: 10.1002/aenm.202001119 – volume: 6 start-page: 0850a7 issue: 8 year: 2019 ident: 87670_CR30 publication-title: Mater. Res. Express doi: 10.1088/2053-1591/ab23e1 – volume: 33 start-page: 103645 issue: 7 year: 2022 ident: 87670_CR62 publication-title: Adv. Powder Technol. doi: 10.1016/j.apt.2022.103645 – volume: 84 start-page: 2004 issue: 9 year: 2021 ident: 87670_CR33 publication-title: Microsc. Res. Tech. doi: 10.1002/jemt.23756 – volume: 230 start-page: 1148 year: 2019 ident: 87670_CR16 publication-title: J. Clean. Prod. doi: 10.1016/j.jclepro.2019.05.157 – volume: 12 start-page: 871 year: 2017 ident: 87670_CR18 publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S122842 – volume: 59 start-page: 993 issue: 10 year: 2021 ident: 87670_CR76 publication-title: Med. Mycol. doi: 10.1093/mmy/myab028 – volume: 66 start-page: 512 issue: 4 year: 2017 ident: 87670_CR92 publication-title: Polym. Int. doi: 10.1002/pi.5304 – volume: 66 start-page: 3063 issue: 12 year: 2018 ident: 87670_CR47 publication-title: J. Agric. Food Chem. doi: 10.1021/acs.jafc.7b05830 – volume: 7 start-page: 315 issue: 4 year: 2020 ident: 87670_CR28 publication-title: Nanomed. J. – volume: 18 start-page: 725 issue: 6 year: 2021 ident: 87670_CR4 publication-title: Mini-Rev. Org. Chem. doi: 10.2174/18756298MTA5jNzYp2 – volume: 506 start-page: 170 year: 2016 ident: 87670_CR66 publication-title: Colloids Surf., a doi: 10.1016/j.colsurfa.2016.05.058 – volume: 64 start-page: 134 issue: 2 year: 2017 ident: 87670_CR69 publication-title: Clin. Infecti. Dis. doi: 10.1093/cid/ciw691 – volume: 11 start-page: 1069 issue: 4 year: 2023 ident: 87670_CR43 publication-title: Microorganisms doi: 10.3390/microorganisms11041069 – volume: 239 start-page: 121976 year: 2020 ident: 87670_CR45 publication-title: Mater. Chem. Phys. doi: 10.1016/j.matchemphys.2019.121976 – volume: 22 start-page: 126 issue: 1 year: 2020 ident: 87670_CR12 publication-title: Biomacromolecules doi: 10.1021/acs.biomac.0c00726 – volume: 194 start-page: 111156 year: 2020 ident: 87670_CR61 publication-title: Colloids Surf. B doi: 10.1016/j.colsurfb.2020.111156 – ident: 87670_CR84 doi: 10.1155/2022/3863138 – volume: 1291 start-page: 136012 year: 2023 ident: 87670_CR41 publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2023.136012 – volume: 57 start-page: 21 year: 2017 ident: 87670_CR56 publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2017.01.020 – volume: 7 start-page: 114 issue: 3 year: 2013 ident: 87670_CR77 publication-title: J. Nanosci. Nanotechnol – volume: 15 start-page: 12186 issue: 16 year: 2023 ident: 87670_CR31 publication-title: Sustainability doi: 10.3390/su151612186 – volume: 20 start-page: 8856 issue: 5 year: 2015 ident: 87670_CR58 publication-title: Molecules doi: 10.3390/molecules20058856 – volume: 139 start-page: 4613 issue: 18 year: 2014 ident: 87670_CR15 publication-title: Analyst doi: 10.1039/C4AN00816B – volume: 10 start-page: 8 year: 2019 ident: 87670_CR89 publication-title: Front. Microbiol. doi: 10.3389/fmicb.2019.00008 – volume: 25 start-page: 664 issue: 3 year: 2011 ident: 87670_CR87 publication-title: Toxicol. In Vitro doi: 10.1016/j.tiv.2011.01.004 – volume: 200 start-page: 111650 year: 2019 ident: 87670_CR9 publication-title: J. Photochem. Photobiol., B doi: 10.1016/j.jphotobiol.2019.111650 – volume: 183 start-page: 30 year: 2018 ident: 87670_CR64 publication-title: J. Photochem. Photobiol., B doi: 10.1016/j.jphotobiol.2018.04.020 – volume: 253 start-page: 124026 year: 2023 ident: 87670_CR20 publication-title: Talanta doi: 10.1016/j.talanta.2022.124026 – volume: 30 start-page: 377 issue: 2 year: 2016 ident: 87670_CR52 publication-title: Infect. Disease Clin. – volume: 53 start-page: 1474 issue: 10 year: 2015 ident: 87670_CR54 publication-title: Pharm. Biol. doi: 10.3109/13880209.2014.986687 – volume: 49 start-page: 182 issue: 2 year: 2016 ident: 87670_CR74 publication-title: J. Microbiol. Immunol. Infect. doi: 10.1016/j.jmii.2014.04.013 – volume: 11 start-page: 341 issue: 1 year: 2018 ident: 87670_CR11 publication-title: Asian J. Pharm. Clin. Res. doi: 10.22159/ajpcr.2018.v11i1.21999 – volume: 83 start-page: 1308 issue: 11 year: 2020 ident: 87670_CR48 publication-title: Microsc. Res. Tech. doi: 10.1002/jemt.23522 – ident: 87670_CR44 doi: 10.1007/s11356-023-25343-8 – volume: 6 start-page: 360 year: 2018 ident: 87670_CR22 publication-title: Front. Chem. doi: 10.3389/fchem.2018.00360 – volume: 2020 start-page: 1215395 issue: 1 year: 2020 ident: 87670_CR93 publication-title: Oxidative Med. Cell. Longev. – ident: 87670_CR21 doi: 10.1016/B978-0-443-15518-5.00024-0 – volume: 9 start-page: 045007 issue: 4 year: 2018 ident: 87670_CR50 publication-title: Adv. Nat. Sci. NanoSci. NanoTechnol. doi: 10.1088/2043-6254/aaec0e – volume: 103 start-page: 1931 issue: 7 year: 2014 ident: 87670_CR59 publication-title: J. Pharm. Sci. doi: 10.1002/jps.24001 – volume: 6 start-page: 13104 issue: 21 year: 2014 ident: 87670_CR2 publication-title: Nanoscale doi: 10.1039/C4NR01405G – volume: 6 start-page: 1 year: 2019 ident: 87670_CR63 publication-title: J. Nanotechnol Nanomed. Nanobiotechnol. doi: 10.24966/NTMB-2044/100022 – volume: 24 start-page: 929 year: 2019 ident: 87670_CR75 publication-title: J. Biol. Inorg. Chem. doi: 10.1007/s00775-019-01717-7 – volume: 15 start-page: 4668 issue: 10 year: 2018 ident: 87670_CR1 publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.8b00640 – volume: 16 start-page: e47 issue: 4 year: 2016 ident: 87670_CR55 publication-title: Lancet. Infect. Dis doi: 10.1016/S1473-3099(16)00078-5 – volume: 10 start-page: 952006 year: 2022 ident: 87670_CR49 publication-title: Front. Chem. doi: 10.3389/fchem.2022.952006 – volume: 15 start-page: 907 issue: 4 year: 2020 ident: 87670_CR7 publication-title: Plasmonics doi: 10.1007/s11468-019-01101-w – volume: 15 start-page: 12783 issue: 17 year: 2023 ident: 87670_CR5 publication-title: Sustainability doi: 10.3390/su151712783 – volume: 11 start-page: 384 year: 2018 ident: 87670_CR10 publication-title: Asian J. Pharm. Clin. Res. doi: 10.22159/ajpcr.2018.v11i3.20858 – volume: 192 start-page: 52 year: 2016 ident: 87670_CR78 publication-title: Microbiol. Res. doi: 10.1016/j.micres.2016.06.004 – volume: 29 start-page: 1601 issue: 7 year: 2018 ident: 87670_CR68 publication-title: Adv. Powder Technol. doi: 10.1016/j.apt.2018.03.025 – volume: 74 start-page: 443 issue: 5 year: 2012 ident: 87670_CR53 publication-title: Indian J. Pharm. Sci. doi: 10.4103/0250-474X.108420 – volume: 28 start-page: 3240 issue: 7 year: 2023 ident: 87670_CR46 publication-title: Molecules doi: 10.3390/molecules28073240 – volume: 41 start-page: 14288 issue: 23 year: 2017 ident: 87670_CR23 publication-title: New J. Chem. doi: 10.1039/C7NJ02453C – volume: 3 start-page: 229 year: 2013 ident: 87670_CR42 publication-title: Appl. Nanosci. doi: 10.1007/s13204-012-0125-5 – volume: 17 start-page: 419 issue: 6 year: 2019 ident: 87670_CR57 publication-title: Expert Rev. anti-infective Therapy doi: 10.1080/14787210.2019.1614914 – volume: 255 start-page: 113358 year: 2019 ident: 87670_CR81 publication-title: Environ. Pollut. doi: 10.1016/j.envpol.2019.113358 – volume: 9 start-page: 1 issue: 1 year: 2017 ident: 87670_CR71 publication-title: Biology Med. doi: 10.4172/0974-8369.1000363 – volume: 8 start-page: 9 issue: 4 year: 2022 ident: 87670_CR82 publication-title: Int. J. Sci. Global Sustain. – volume: 17 start-page: 968 issue: 2 year: 2017 ident: 87670_CR13 publication-title: J. Nanosci. Nanotechnol. doi: 10.1166/jnn.2017.12636 – volume: 7 start-page: e06923 issue: 4 year: 2021 ident: 87670_CR65 publication-title: Heliyon doi: 10.1016/j.heliyon.2021.e06923 – volume: 1199 start-page: 126979 year: 2020 ident: 87670_CR34 publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2019.126979 – volume: 14 start-page: 2075 issue: 3 year: 2020 ident: 87670_CR79 publication-title: J. Pure Appl. Microbiol. doi: 10.22207/JPAM.14.3.48 – volume: 124 start-page: 108385 year: 2021 ident: 87670_CR27 publication-title: Inorg. Chem. Commun. doi: 10.1016/j.inoche.2020.108385 – ident: 87670_CR32 doi: 10.1016/B978-0-323-46139-9.00001-3 – volume: 53 start-page: 102870 year: 2023 ident: 87670_CR19 publication-title: Biocatal. Agric. Biotechnol. doi: 10.1016/j.bcab.2023.102870 – volume: 18 start-page: 2101 issue: 4 year: 2019 ident: 87670_CR26 publication-title: Iran. J. Pharm. Research: IJPR |
| SSID | ssj0000529419 |
| Score | 2.4457402 |
| Snippet | One of the popular subjects of millennia is the synthesis of nanostructures, their applications in numerous fields, and their interaction with various... Abstract One of the popular subjects of millennia is the synthesis of nanostructures, their applications in numerous fields, and their interaction with various... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 13466 |
| SubjectTerms | 631/449 631/45 Animals Anti-Infective Agents - chemistry Anti-Infective Agents - pharmacology Anticancer Antimicrobial Antimicrobial activity Antimicrobial agents Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Antioxidants Antioxidants - chemistry Antioxidants - pharmacology Artemia - drug effects Bacteria - drug effects Biocompatibility Biosynthesis Cancer Cell lines Chlorocebus aethiops Clinical trials Crystals Cytotoxic Cytotoxicity Drug delivery Drug delivery systems E. sativa Green Chemistry Technology HEK293 Cells Humanities and Social Sciences Humans Metal Nanoparticles - chemistry Microbial Sensitivity Tests multidisciplinary Nanoparticles Oxides - chemistry Oxides - pharmacology Plant Extracts - chemistry Plant Extracts - pharmacology Science Science (multidisciplinary) Silver Silver Compounds - chemistry Silver Compounds - pharmacology Silver oxide nanoparticles Strains (organisms) Ultraviolet spectroscopy Vero Cells Zeta potential |
| SummonAdditionalLinks | – databaseName: DOAJ Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA9SEHwRv11bJYJvujSfu8mjypVSqE8W-hZySRYPJCvutXj_fWeSvbPnB774mmyWJDPJ_IbM_IaQN14zAV5AaC3zqVXR29bzAI5rSJaZJWhMqUVw_qk7vVBnl_ryVqkvjAmr9MB1445DBEwDPooGU6fAXPmQ5FLG2HMxGGjA2xds3i1nqrJ6C6u4nbNkmDTHE1gqzCYTGi-AnrV2zxIVwv4_oczfgyV_eTEthujkAbk_I0j6vs78IbmT8iNyt9aU3Dwm60UYByQvjl83dNpkAHjTaqJhR8xc8y6pz5FWBiYUE8X8huvCrkrHgS5A4p5ioM-1pyW5BIApnVYYRk3HH6uYaPYZ_O05rO4JuThZfP542s6lFdqgrFq3AwtYoCZ0SgPk6YzomR1gjcteRBsHbyIPvQrIjd91WqbojZLRCnCAgvY-yKfkII85PScUjnSw3ssO_qlYUsZqhCGG6yEJ1bGGvN1us_tWGTRcefmWxlWhOBCKK0JxtiEfUBK7L5H9ujSATrh5Ue5fOtGQo60c3XwkJyeRyQ5fSXlDXu-64TDhC4nPabyq33TcAAxtyLMq9t1MFHpjQsBos6cQe1Pd78mrL4Wwm2OQieIw9N1Wd37O6-978eJ_7MUhuSdQ6ZGe0hyRg_X3q_QScNR6-aocmRu9nhiU priority: 102 providerName: Directory of Open Access Journals – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKERIX1PJMH8hI3CDCduzEPpbVVhUSnKjUm-W1HVgJOVWzrdh_z4zzQAvlwDW2I9szE3-TmflMyFunmAAvwJeGuVjK4EzpuAfH1UfD9Ao0Jt9F8PlLfXEpP12pqz0iplqYnLSfKS3zZ3rKDvvQw0GDxWBCof02rDQPyEOkbketXtSL-b8KRq4kN2N9DKv0PUN3zqBM1X8fvvw7TfKPWGk-gs4PyJMRO9KzYbaHZC-mp-TRcJvk9hnZLH3XIm1x-LGl_TYBtOvXPfUzJfNQcUldCnTgXkIBUaxsuMu8qrRr6RJk7Sim-Nw5mstKAJLSfo0J1LT7uQ6RJpfA0x637Dm5PF9-XVyU46UKpZdGbsqWebyaxtdSAdiptWiYaWGNq0YEE1qnA_eN9Hlra1XF4LSsghHg-njlnK9ekP3UpfiKUDBmb5yraninZFFqoxCAaK7aKGTNCvJu2mZ7PXBn2BzzrrQdhGJBKDYLxZqCfERJzD2R9zo_6G6-2XFR1gdAuOCxKgA-EsCL87FaVSE0XLQaHhTkZJKjHY2xtxVy2GF8lBfkzdwMZoSxEZdidzv0qbkGAFqQl4PY55lI9MOEgNF6RyF2prrbktbfM1U3x_QSyWHo-0l3fs_r33tx9H_dj8ljgeqNFJT6hOxvbm7jKWClzep1No5f0FIPIw priority: 102 providerName: Springer Nature |
| Title | Ecofriendly synthesis characterization and biological activities of Eruca sativa mediated silver oxide nanoparticles |
| URI | https://link.springer.com/article/10.1038/s41598-025-87670-9 https://www.ncbi.nlm.nih.gov/pubmed/40251221 https://www.proquest.com/docview/3191481661 https://www.proquest.com/docview/3191618085 https://pubmed.ncbi.nlm.nih.gov/PMC12008411 https://doaj.org/article/cd08010757434820ace3b3dd712f8482 |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdby2Avo92nuzZosLfN1JZlWXoqaUgpgZWxrZA3oUjyGhh2V6el-e93Jysu2deTQf5A8p2k3-nufkfIe1NmDKwAm6rM-JQ7o1KTWzBcrVeZXIDGhFoEny7E-SWfzct5PHDrYljlZk0MC7VrLZ6RHxdIRIZOrvzk-meKVaPQuxpLaDwmu0hdhiFd1bwazljQi8VzFXNlskIed7BfYU4ZK3EZqLJUbe1Hgbb_b1jzz5DJ3_ymYTs62yPPIo6k417w--SRb56TJ31lyfULspratkYKY_djTbt1AzCvW3bUDvTMffYlNY2jPQ8TCotilsNd4FilbU2nIHdDMdznztCQYgLwlHZLDKam7f3SedqYBqzuGFz3klyeTb9NztNYYCG1XPFVWmcWy9RYwUsAPkKyKlM1jHFRMadcbaTLbcUtMuQLURbeGckLpxiYQbY0xhavyE7TNv4NoTCxrTKmEPBNnnkuVYlgROZl7RkXWUI-bH6zvu55NHTwfxdS90LRIBQdhKJVQk5REsOTyIEdGtqb7zoOSlsHaBes1xJAEAcgY6wvFoVzVc5qCQ0JOdzIUceJ2ekHNUrIu-E2TCn0k5jGt7f9MyKXAEYT8roX-9ATjjYZY_C23FKIra5u32mWV4G2O8dQE57Dqx83uvPQr3__i4P_D-MtecpQnZF-Uh6SndXNrT8CnLRajMJkGJHd8Xj2dQbX0-nF5y_QOhGTUTh7-AU2iRYp |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrRBcEG8CBYwEJ4iaOE5iHxCisNWWtiuEWqk312s7sBJKSrMt7J_iNzKTV7W8br3mJcczHn_jmfkG4LlJI45egA1VZHwonFGhiS06rtarSM5QY5peBPvTbHIoPhylR2vws6-FobTK3iY2htpVls7INxMiIqMgV_zm5FtIXaMoutq30GjVYtcvv6PLVr_eeY_yfcH59vjg3STsugqEViixCIvIUm8Wm4kUd_tM8jxShXd2lnOnXGGki20uLNHCZ1maeGekSJziiP1taoxN8LtXYF0k6MqMYH1rPP34aTjVobiZiFVXnRMlcrPGHZKq2HhKhiePQrWyAzaNAv6Gbv9M0vwtUttsgNs34UaHXNnbVtVuwZovb8PVtpfl8g4sxrYqiDTZfV2yelkisKznNbMDIXRb78lM6VjL_ETqwaiu4rxhdWVVwcaoaYZRgtG5YU1RCwJiVs8pfZtVP-bOs9KU6Od36Xx34fBSJv8ejMqq9A-AoSmxypgkw2-KyAupUoI_Mk4Lz0UWBfCyn2Z90jJ36CbinkjdCkWjUHQjFK0C2CJJDE8S63ZzoTr9rLuf0tYhvkZ_OUXYJRA6GeuTWeJcHvNC4oUANno56s4U1PpCcQN4NtzGRUyRGVP66qx9Joslwt8A7rdiH0YiyAvkHN-WKwqxMtTVO-X8S0MUHlNyi4jx1Ve97lyM699z8fD_v_EUrk0O9vf03s509xFc56TaRH4pN2C0OD3zjxGlLWZPuqXB4PiyV-MvunVPEg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEagXxJtAASPBCaJN_EjsA0JAd9VSqDhQaW_GazuwUpWUZlvYv8avY8ZJtlpet17zkuOZsb_xzHxDyFMrMwZegEt1ZkMqvNWpzR04ri7oTM1AY2Ivgg8Hxe6heDeV0w3yc6iFwbTKYU2MC7VvHJ6RjzgSkWGQKx9VfVrEx53Jq-NvKXaQwkjr0E6jU5H9sPwO7lv7cm8HZP2Mscn409vdtO8wkDqhxSKtMod9WlwhJOz8hWJlpqvg3axkXvvKKp-7UjikiC8KyYO3SnCvGfgBTlrrOHz3ErlccpmjjZXTcnW-gxE0keu-TifjatTCXon1bEziElRmqV7bC2PLgL_h3D_TNX-L2catcHKdXOsxLH3dKd0NshHqm-RK19VyeYssxq6pkD7ZHy1pu6wBYrbzlroVNXRX-Ult7WnHAYWKQrHC4izyu9KmomPQOUsx1ejM0ljeAtCYtnNM5KbNj7kPtLY1ePx9Yt9tcnghU3-HbNZNHe4RCouK09byAr4psiCUlgiEVC6rwESRJeT5MM3muOPwMDH2zpXphGJAKCYKxeiEvEFJrJ5E_u14oTn5YvqfMs4D0gbPWQIAEwCirAt8xr0vc1YpuJCQ7UGOpl8UWnOuwgl5sroN5owxGluH5rR7psgVAOGE3O3EvhqJQH-QMXhbrSnE2lDX79Tzr5EyPMc0F5HDqy8G3Tkf17_n4v7_f-MxuQo2aN7vHew_IFsMNRtZMNU22VycnIaHANcWs0fRLij5fNGG-AucVVHi |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ecofriendly+synthesis+characterization+and+biological+activities+of+Eruca+sativa+mediated+silver+oxide+nanoparticles&rft.jtitle=Scientific+reports&rft.date=2025-04-18&rft.pub=Nature+Publishing+Group&rft.eissn=2045-2322&rft.volume=15&rft.issue=1&rft.spage=13466&rft_id=info:doi/10.1038%2Fs41598-025-87670-9&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |